Consolidated Condensed Statements of Stockholders Deficit (Unaudited) - USD ($) shares in Thousands, $ in Millions	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Loss
Balance (in shares) at Oct. 31, 2021		1,092,205
Balance at beginning of period at Oct. 31, 2021	$ (1,650)	$ 11	$ 1,060	$ (2,461)	$ (260)
Increase (Decrease) in Stockholders' Equity
Net earnings	1,086			1,086
Other comprehensive income (loss), net of taxes	244				244
Comprehensive (loss) income	1,330
Issuance of common stock in connection with employee stock plans and other (in shares)		9,777
Issuance of common stock in connection with employee stock plans and other	$ (106)		(106)
Repurchases of common stock (in shares)	(42,000)	(42,082)
Repurchases of common stock (Note 10)	$ (1,499)		(41)	(1,458)
Cash dividends	(536)			(536)
Stock-based compensation expense	133		133
Balance (in shares) at Jan. 31, 2022		1,059,900
Balance at end of period at Jan. 31, 2022	$ (2,328)	$ 11	1,046	(3,369)	(16)
Balance (in shares) at Oct. 31, 2022	980,000	979,869
Balance at beginning of period at Oct. 31, 2022	$ (2,918)	$ 10	1,172	(4,413)	313
Increase (Decrease) in Stockholders' Equity
Net earnings	487			487
Other comprehensive income (loss), net of taxes	(769)				(769)
Comprehensive (loss) income	(282)
Issuance of common stock in connection with employee stock plans and other (in shares)		8,844
Issuance of common stock in connection with employee stock plans and other	$ (79)		(79)
Repurchases of common stock (in shares)	(3,600)	(3,624)
Repurchases of common stock (Note 10)	$ (100)		(4)	(96)
Cash dividends	(518)			(518)
Stock-based compensation expense	$ 167		167
Balance (in shares) at Jan. 31, 2023	985,000	985,089
Balance at end of period at Jan. 31, 2023	$ (3,730)	$ 10	$ 1,256	$ (4,540)	$ (456)